These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 15102356)

  • 1. Selective depletion of activated T cells: the CD40L-specific antibody experience.
    Hargreaves RE; Monk NJ; Jurcevic S
    Trends Mol Med; 2004 Mar; 10(3):130-5. PubMed ID: 15102356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fc-dependent depletion of activated T cells occurs through CD40L-specific antibody rather than costimulation blockade.
    Monk NJ; Hargreaves RE; Marsh JE; Farrar CA; Sacks SH; Millrain M; Simpson E; Dyson J; Jurcevic S
    Nat Med; 2003 Oct; 9(10):1275-80. PubMed ID: 14502279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LIGHT costimulates CD40 triggering and induces immunoglobulin secretion; a novel key partner in T cell-dependent B cell terminal differentiation.
    Duhen T; Pasero C; Mallet F; Barbarat B; Olive D; Costello RT
    Eur J Immunol; 2004 Dec; 34(12):3534-41. PubMed ID: 15549770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of chronic rejection and development of tolerogenic T cells after ICOS-ICOSL and CD40-CD40L co-stimulation blockade.
    Guillonneau C; Aubry V; Renaudin K; Séveno C; Usal C; Tezuka K; Anegon I
    Transplantation; 2005 Aug; 80(4):546-54. PubMed ID: 16220623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-cell expansion in the presence of the novel 293-CD40L-sCD40L cell line allows the generation of large numbers of efficient xenoantigen-free APC.
    Ivanov R; Aarts T; Hagenbeek A; Hol S; Ebeling S
    Cytotherapy; 2005; 7(1):62-73. PubMed ID: 16040385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB promotes long-term survival in skin allografts treated with anti-CD45RB and anti-CD40L monoclonal antibodies.
    Lee J; Lee EN; Kim EY; Lee HJ; Park HJ; Sun CL; Lee SK; Joh JW; Lee KW; Kwon GY; Kim SJ
    Transplant Proc; 2005; 37(1):123-5. PubMed ID: 15808569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of T cell activation by immobilized hu5C8 (anti-CD40L) monoclonal antibody.
    Arpinati M; Chirumbolo G; Rondelli D
    Eur J Haematol; 2008 Apr; 80(4):322-30. PubMed ID: 18081708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete rejection of a T-cell lymphoma due to synergism of T-cell receptor costimulatory molecules, CD80, CD40L, and CD40.
    Ruybal P; Gravisaco MJ; Barcala V; Escalada A; Di Sciullo P; Waldner C; Mongini C
    Vaccine; 2008 Jan; 26(5):697-705. PubMed ID: 18155328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation and characterization of a novel anti-rat CD40L antibody with inhibitory activities in vitro and in vivo.
    Stax AM; Gelderman KA; Kamerling SW; van der Geest R; Schlagwein N; van Kooten C
    J Immunol Methods; 2008 Jun; 335(1-2):46-52. PubMed ID: 18384807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-stimulation with 4-1BB ligand allows extended T-cell proliferation, synergizes with CD80/CD86 and can reactivate anergic T cells.
    Habib-Agahi M; Phan TT; Searle PF
    Int Immunol; 2007 Dec; 19(12):1383-94. PubMed ID: 17977894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.
    Davis ID; Chen Q; Morris L; Quirk J; Stanley M; Tavarnesi ML; Parente P; Cavicchiolo T; Hopkins W; Jackson H; Dimopoulos N; Tai TY; MacGregor D; Browning J; Svobodova S; Caron D; Maraskovsky E; Old LJ; Chen W; Cebon J
    J Immunother; 2006; 29(5):499-511. PubMed ID: 16971806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Costimulatory molecule CD154 in systemic lupus erythematosus and rheumatoid arthritis. Therapeutic perspectives.
    Dejica DI; Manea EM
    Roum Arch Microbiol Immunol; 2006; 65(1-2):66-74. PubMed ID: 17877113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of CD40/CD40 ligand interactions attenuates skin fibrosis and autoimmunity in the tight-skin mouse.
    Komura K; Fujimoto M; Yanaba K; Matsushita T; Matsushita Y; Horikawa M; Ogawa F; Shimizu K; Hasegawa M; Takehara K; Sato S
    Ann Rheum Dis; 2008 Jun; 67(6):867-72. PubMed ID: 17823201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B cells play a cooperative role via CD40L-CD40 interaction in T cell-mediated experimental autoimmune neuritis in Lewis rats.
    Zhu W; Mix E; Jin T; Adem A; Zhu J
    Neurobiol Dis; 2007 Mar; 25(3):642-8. PubMed ID: 17188497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell costimulatory molecules: optimal targets for the treatment of allergic airway disease with monoclonal antibodies.
    Kroczek R; Hamelmann E
    J Allergy Clin Immunol; 2005 Oct; 116(4):906-9. PubMed ID: 16210068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimer stabilization, oligomerization, and antibody-mediated cell surface immobilization improve the activity of soluble trimers of CD27L, CD40L, 41BBL, and glucocorticoid-induced TNF receptor ligand.
    Wyzgol A; Müller N; Fick A; Munkel S; Grigoleit GU; Pfizenmaier K; Wajant H
    J Immunol; 2009 Aug; 183(3):1851-61. PubMed ID: 19596991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40L, CD28, and CTLA-4 expression on CD4+ T cells in kidney graft recipients: a relationship with post-transplantation clinical course.
    Kosmaczewska A; Magott-Procelewska M; Frydecka I; Ciszak L; Bocko D; Szteblich A; Kusnierczyk P; Patrzalek D; Szyber P; Klinger M
    Transpl Immunol; 2006 Jun; 16(1):32-40. PubMed ID: 16701174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A GM-CSF/CD40L producing cell augments anti-tumor T cell responses.
    Dessureault S; Alsarraj M; McCarthy S; Hunter T; Noyes D; Lee D; Harkins J; Seigne J; Jennings R; Antonia SJ
    J Surg Res; 2005 May; 125(2):173-81. PubMed ID: 15854671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic peptidomimetic strategies for autoimmune diseases: costimulation blockade.
    Allen SD; Rawale SV; Whitacre CC; Kaumaya PT
    J Pept Res; 2005 Jun; 65(6):591-604. PubMed ID: 15885118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-Lymphocytes activated by CD40 ligand induce an antigen-specific anti-tumour immune response by direct and indirect activation of CD8(+) T-cells.
    Ritchie DS; Yang J; Hermans IF; Ronchese F
    Scand J Immunol; 2004 Dec; 60(6):543-51. PubMed ID: 15584965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.